Publication | Closed Access

Further evidence of antigenic drift and protective efficacy afforded by a recombinant HVT-H5 vaccine against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains

VaccinationVaccine DevelopmentHpai H5n1 StrainsRecombinant Hvt-h5 VaccineImmunologyVaccine TestingVirologyAntigenic DriftVaccine DesignMedicineVaccine Research